Market Overview:
The global next generation sequencing (NGS) sample preparation market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market is segmented by type, application, and region. By type, the SBS sequencing segment is expected to hold the largest share of the market in 2018. However, the nanopore sequencing segment is projected to grow at the highest CAGR during the forecast period. By application, biopharmaceutical companies are expected to hold the largest share of the market in 2018; however, hospitals are projected to grow at a higher rate duringthe forecast period.
 Sample Preparation Industry Outlook.svg)
Product Definition:
Next generation sequencing (NGS) sample preparation is the process of extracting genetic material from a biological sample and preparing it for sequencing. NGS sample preparation is important because it allows scientists to extract DNA or RNA from a variety of samples, including blood, tissue, and cells. This process helps to ensure that the genetic material is in a format that can be sequenced accurately.
Sequencing by Synthesis (SBS):
Sequencing by synthesis is a new technology that allows the preparation of DNA or RNA samples for sequencing without the need for PCR amplification. It also enables efficient and cost-effective generation of high-quality data. The technology has been around since 2010 but it's only now starting to be used in many different applications such as next-generation sequencing, clinical diagnostics, forensics & genetic disease testing and plant & animal breeding.
Ion Semiconductor Sequencing:
Ion semiconductor sequencing is a new technology that allows rapid and cost-effective preparation of DNA or RNA samples for next-generation sequencing. It also helps in the detection of rare and common genetic diseases with the help of NGS technology. Ion semiconductor sequencing involves using anion as electron acceptor during amplification, which generates multiple ions as a byproduct during process thus enabling faster reaction rates.
Application Insights:
The biopharmaceutical companies segment dominated the market in 2017 and is expected to witness lucrative growth over the forecast period. This can be attributed to increasing R&D activities pertaining to NGS technology for discovering novel drugs with higher efficacy and fewer side effects. Moreover, an increase in product launches by various companies such as Illumina, Inc., Foundation Medicine, Inc., and others are expected to boost revenue generation.
The hospitals segment is also anticipated to witness significant growth owing to rising adoption of NGS technology for various research studies including personalized medicine, drug discovery & development, infectious disease management & control along with other applications such as genetic testing for patients suffering from rare diseases or cancer susceptibility. In addition, an increase in research initiatives by major players such as Illumina Corporation and Foundation Medicine are likely further boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increased funding for NGS technologies and high adoption rate of advanced technologies in this region. Moreover, increasing prevalence of cancer and other genetic disorders is also expected to drive the regional demand for NGS sample preparation over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by governments as well as private companies in emerging economies such as China and India. For instance, Novogene Corporation invested around USD X million for building a sequencing factory in China which will have an ability to sequence 1 million human genomes per year after its completion. Such investments are anticipated boost revenue generation from Asia Pacific during the forecast period – from 2018 to 2030 (forecast).
Growth Factors:
- Increasing demand for NGS services from the life science research community for studying gene expression, genotyping and sequencing of genomes
- Growing application of NGS in diagnostics and personalized medicine
- Advances in technology that have led to development of new sequencing platforms and kits, which are more efficient and produce higher quality data
- Proliferation of next-generation sequencers in academic institutions, hospitals and commercial laboratories
- Rising funding for NGS research by government agencies and private foundations
Scope Of The Report
Report Attributes
Report Details
Report Title
Next Generation Sequencing (NGS) Sample Preparation Market Research Report
By Type
Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single Molecule Real Time (SMRT) Sequencing, Nanopore Sequencing
By Application
Biopharmaceutical Companies, Hospitals, Academics & Research Institutes, Other
By Companies
Agilent Technologies，Inc., Thermo Fisher Scientific, Macrogen，Inc, Illumina，Inc., Eurofins Scientific, QIAGEN N.V., F Hoffman-La Roche AG, Beckman Coulter (Danaher)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Next Generation Sequencing (NGS) Sample Preparation Market Report Segments:
The global Next Generation Sequencing (NGS) Sample Preparation market is segmented on the basis of:
Types
Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single Molecule Real Time (SMRT) Sequencing, Nanopore Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Hospitals, Academics & Research Institutes, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies，Inc.
- Thermo Fisher Scientific
- Macrogen，Inc
- Illumina，Inc.
- Eurofins Scientific
- QIAGEN N.V.
- F Hoffman-La Roche AG
- Beckman Coulter (Danaher)
 Sample Preparation Market Overview.svg)
Highlights of The Next Generation Sequencing (NGS) Sample Preparation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing
- Single Molecule Real Time (SMRT) Sequencing
- Nanopore Sequencing
- By Application:
- Biopharmaceutical Companies
- Hospitals
- Academics & Research Institutes
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Next Generation Sequencing (NGS) Sample Preparation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Sample Preparation Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Next Generation Sequencing (NGS) is a technology that uses DNA sequencing to identify the sequence of nucleotides in a sample. NGS can be used to study large numbers of samples at once, which makes it an important tool for research and diagnostics.
Some of the major players in the next generation sequencing (ngs) sample preparation market are Agilent Technologies，Inc., Thermo Fisher Scientific, Macrogen，Inc, Illumina，Inc., Eurofins Scientific, QIAGEN N.V., F Hoffman-La Roche AG, Beckman Coulter (Danaher).
The next generation sequencing (ngs) sample preparation market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Next Generation Sequencing (NGS) Sample Preparation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Next Generation Sequencing (NGS) Sample Preparation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Next Generation Sequencing (NGS) Sample Preparation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Next Generation Sequencing (NGS) Sample Preparation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Next Generation Sequencing (NGS) Sample Preparation Market Size & Forecast, 2018-2028
4.5.1 Next Generation Sequencing (NGS) Sample Preparation Market Size and Y-o-Y Growth
4.5.2 Next Generation Sequencing (NGS) Sample Preparation Market Absolute $ Opportunity
Chapter 5 Global Next Generation Sequencing (NGS) Sample Preparation Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Type
5.2.1 Sequencing by Synthesis (SBS)
5.2.2 Ion Semiconductor Sequencing
5.2.3 Single Molecule Real Time (SMRT) Sequencing
5.2.4 Nanopore Sequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Next Generation Sequencing (NGS) Sample Preparation Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 Hospitals
6.2.3 Academics & Research Institutes
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Next Generation Sequencing (NGS) Sample Preparation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Next Generation Sequencing (NGS) Sample Preparation Analysis and Forecast
9.1 Introduction
9.2 North America Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Type
9.6.1 Sequencing by Synthesis (SBS)
9.6.2 Ion Semiconductor Sequencing
9.6.3 Single Molecule Real Time (SMRT) Sequencing
9.6.4 Nanopore Sequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 Hospitals
9.10.3 Academics & Research Institutes
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Next Generation Sequencing (NGS) Sample Preparation Analysis and Forecast
10.1 Introduction
10.2 Europe Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Type
10.6.1 Sequencing by Synthesis (SBS)
10.6.2 Ion Semiconductor Sequencing
10.6.3 Single Molecule Real Time (SMRT) Sequencing
10.6.4 Nanopore Sequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 Hospitals
10.10.3 Academics & Research Institutes
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Next Generation Sequencing (NGS) Sample Preparation Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Type
11.6.1 Sequencing by Synthesis (SBS)
11.6.2 Ion Semiconductor Sequencing
11.6.3 Single Molecule Real Time (SMRT) Sequencing
11.6.4 Nanopore Sequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 Hospitals
11.10.3 Academics & Research Institutes
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Next Generation Sequencing (NGS) Sample Preparation Analysis and Forecast
12.1 Introduction
12.2 Latin America Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Type
12.6.1 Sequencing by Synthesis (SBS)
12.6.2 Ion Semiconductor Sequencing
12.6.3 Single Molecule Real Time (SMRT) Sequencing
12.6.4 Nanopore Sequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 Hospitals
12.10.3 Academics & Research Institutes
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Next Generation Sequencing (NGS) Sample Preparation Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Type
13.6.1 Sequencing by Synthesis (SBS)
13.6.2 Ion Semiconductor Sequencing
13.6.3 Single Molecule Real Time (SMRT) Sequencing
13.6.4 Nanopore Sequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Next Generation Sequencing (NGS) Sample Preparation Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 Hospitals
13.10.3 Academics & Research Institutes
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Next Generation Sequencing (NGS) Sample Preparation Market: Competitive Dashboard
14.2 Global Next Generation Sequencing (NGS) Sample Preparation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agilent Technologies，Inc.
14.3.2 Thermo Fisher Scientific
14.3.3 Macrogen，Inc
14.3.4 Illumina，Inc.
14.3.5 Eurofins Scientific
14.3.6 QIAGEN N.V.
14.3.7 F Hoffman-La Roche AG
14.3.8 Beckman Coulter (Danaher)
